A Decentralized Model to Amplify COVID-19 Testing Capability

Our solution leverages existing laboratory capabilities and enhances testing capacity to help us beat COVID-19. If you are a laboratory possessing highly-skilled personnel and equipment, you could help us scale COVID-19 Testing.

Read the White Paper Join us on Slack

The Problem

Conventional Testing Doesn't Scale

Crucial Testing Shortage

The COVID-19 pandemic has stretched our diagnostic testing capacity: the number of tests available do not meet the population's needs. Testing is conventionally performed at clinical labs with pre-assembled kits, strictly bound to the manufacturer’s instructions.

Conventional Testing: "Rule-in"

Most tests use a “rule in” approach: a positive result confirms a patient has the disease. These conventional tests are challenging to implement and have logistical and supply chain constraints. If any part of the kit is unavailable, or if the instructions cannot be exactly followed, testing cannot be performed. Additionally, these tests require specific instrumentation and have defined training or state licensing requirements for personnel running the tests.

Massive Backlogs

If more tests are needed than a laboratory can accommodate, the resulting backlog will significantly delay or invalidate specimen testing. With the number of COVID-19 infections growing each day, we need a solution to rapidly scale testing capacity nationally and globally.

Our Solution

We propose a "Rule-Out" Lab Developed Test (LDT) and regulatory framework which is readily implementable

Decentralized "Rule-out" Testing

Our team has created a novel decentralized approach that can exponentially increase COVID-19 testing capacity. Utilizing existing equipment and highly trained personnel from non-conventional academic and research labs across the U.S, our decentralized model draws on instruments and reagents from outside the strained supply chain to set up rule-out testing for underserved populations.

Exponential Increase in Testing Capacity

Thus far, under 500,000 COVID-19 tests have been performed in the United States. Our model would provide a scalable framework to perform over 150,000 tests per day in California alone. The unprecedented COVID-19 pandemic has created a monumental surge in testing demand over a period of weeks, and our solution enables critical testing capabilities for the people most in need.

Conservation of Critical Supplies

Our model conserves short-supply conventional tests for those with the greatest likelihood of infection.